ArticlePloS one2013
MIP-2A is a novel target of an anilinoquinazoline derivative for inhibition of tumour cell proliferation.
Mayuko Tokunaga et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticlePloS one2013
Mayuko Tokunaga et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.